{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:11:30Z","timestamp":1774523490615,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,5,3]],"date-time":"2014-05-03T00:00:00Z","timestamp":1399075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s11095-014-1372-9","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T17:03:19Z","timestamp":1399050199000},"page":"2748-2761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Enhancement of Nasal HIV Vaccination with Adenoviral Vector-Based Nanocomplexes Using Mucoadhesive and DC-Targeting Adjuvants"],"prefix":"10.1007","volume":"31","author":[{"given":"Yuhong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,3]]},"reference":[{"key":"1372_CR1","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","volume":"77","author":"DR Casimiro","year":"2003","unstructured":"Casimiro DR, Chen L, Fu T-M, et al. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol. 2003;77:6305\u201313.","journal-title":"J Virol"},{"key":"1372_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/hum.2005.16.149","volume":"16","author":"DH Barouch","year":"2005","unstructured":"Barouch DH, Nabel GJ. Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum Gene Ther. 2005;16:149\u201356.","journal-title":"Hum Gene Ther"},{"key":"1372_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2012.07.056","volume":"425","author":"M Shoji","year":"2012","unstructured":"Shoji M et al. Type-I IFN signaling is required for the induction of antigen-specific CD8+T cell responses by adenovirus vector vaccine in the gut-mucosa. Biochem Biophys Res Commun. 2012;425:89\u201393.","journal-title":"Biochem Biophys Res Commun"},{"key":"1372_CR4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/509258","volume":"194","author":"AT Catanzaro","year":"2006","unstructured":"Catanzaro AT, Koup RA, Roederer M, Bailer RT. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J Infect Dis. 2006;194:1638\u20139.","journal-title":"J Infect Dis"},{"key":"1372_CR5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.vaccine.2003.08.029","volume":"22","author":"AR Pinto","year":"2004","unstructured":"Pinto AR, Fitzgerald JC, Gao GP, Wilson JM, Ertl HCJ. Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector. Vaccine. 2004;22:697\u2013703.","journal-title":"Vaccine"},{"key":"1372_CR6","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","volume":"110","author":"N Tatsis","year":"2007","unstructured":"Tatsis N, Fitzgerald JC, et al. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood. 2007;110:1916\u201323.","journal-title":"Blood"},{"key":"1372_CR7","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","volume":"77","author":"ZQ Xiang","year":"2003","unstructured":"Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HCJ. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier. J Virol. 2003;77:10780\u2013809.","journal-title":"J Virol"},{"key":"1372_CR8","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","volume":"10","author":"MA Croyle","year":"2008","unstructured":"Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, et al. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. PLoS ONE. 2008;10:e3548.","journal-title":"PLoS ONE"},{"key":"1372_CR9","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1016\/j.vaccine.2010.08.006","volume":"28","author":"WM Gwinn","year":"2010","unstructured":"Gwinn WM et al. Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1. Vaccine. 2010;28:6901\u201314.","journal-title":"Vaccine"},{"key":"1372_CR10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nmat2784","volume":"9","author":"T Nochi","year":"2010","unstructured":"Nochi T et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater. 2010;9:574\u20138.","journal-title":"Nat Mater"},{"key":"1372_CR11","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0264-410X(98)00449-6","volume":"17","author":"Z Xiang","year":"1999","unstructured":"Xiang Z, Ertl HCJ. Induction of mucosal immunity with a replication-defective adenoviral recombinant. Vaccine. 1999;17:2003\u20138.","journal-title":"Vaccine"},{"key":"1372_CR12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2009.08.018","volume":"140","author":"N Hagenaars","year":"2009","unstructured":"Hagenaars N, Verheul RJ. Relationship between structure and adjuvanticity of N, N, N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine. J Control Release. 2009;140:126\u201333.","journal-title":"J Control Release"},{"key":"1372_CR13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/sj.gt.3302312","volume":"11","author":"M Koping-Hoggard","year":"2004","unstructured":"Koping-Hoggard M, Varum KM, et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 2004;11:1441\u201352.","journal-title":"Gene Ther"},{"key":"1372_CR14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2008.03.016","volume":"359","author":"Y Gao","year":"2008","unstructured":"Gao Y, Hea L, Katsumi H. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. Int J Pharm. 2008;359:70\u20138.","journal-title":"Int J Pharm"},{"key":"1372_CR15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0142-9612(01)00090-4","volume":"23","author":"M Thanou","year":"2002","unstructured":"Thanou M, Florea BI, Geldof M, Junginger HE, Borchard G. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials. 2002;23:153\u20139.","journal-title":"Biomaterials"},{"key":"1372_CR16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jconrel.2005.01.001","volume":"103","author":"T Kean","year":"2005","unstructured":"Kean T, Roth S, Thanou M. Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency. J Control Release. 2005;103:643\u201353.","journal-title":"J Control Release"},{"key":"1372_CR17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nbt.2344","volume":"30","author":"F Wegmann","year":"2012","unstructured":"Wegmann F et al. Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens. Nat Biotechnol. 2012;30:883\u20138.","journal-title":"Nat Biotechnol"},{"key":"1372_CR18","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/sj.gt.3302054","volume":"10","author":"K Regnstr\u00f6m","year":"2003","unstructured":"Regnstr\u00f6m K, Ragnarsson EGE, et al. PEI\u2014a potent, but not harmless, mucosalimmuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice. Gene Ther. 2003;10:1575\u201383.","journal-title":"Gene Ther"},{"key":"1372_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pep.2006.02.017","volume":"48","author":"M Kirschner","year":"2006","unstructured":"Kirschner M et al. The production of cleaved, trimeric human immunodeWciency virus type 1 (HIV-1) envelope glycoprotein vaccine antigens and infectious pseudoviruses using linear polyethylenimine as a transfection reagent. Protein Expr Purif. 2006;48:61\u20138.","journal-title":"Protein Expr Purif"},{"key":"1372_CR20","doi-asserted-by":"crossref","first-page":"105106","DOI":"10.1088\/0957-4484\/21\/10\/105106","volume":"21","author":"J Han","year":"2010","unstructured":"Han J, Zhao D, Zhong Z, Zhang Z, Gong T, Sun X. Combination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transduction. Nanotechnology. 2010;21:105106. 10pp.","journal-title":"Nanotechnology"},{"key":"1372_CR21","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2147\/IJN.S31760","volume":"7","author":"X Sun","year":"2012","unstructured":"Sun X, Chen SM, et al. Mannosylated biodegradable polyethyleneimine for targeted DNA delivery to dendritic cells. Int J Nanomed. 2012;7:2929\u201342.","journal-title":"Int J Nanomed"},{"key":"1372_CR22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13346-012-0085-z","volume":"3","author":"M Zaman","year":"2013","unstructured":"Zaman M et al. Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res. 2013;3:100\u20139.","journal-title":"Drug Deliv Transl Res"},{"key":"1372_CR23","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","volume":"176","author":"K Inaba","year":"1992","unstructured":"Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor. J Exp Med. 1992;176:1693\u2013702.","journal-title":"J Exp Med"},{"key":"1372_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.171.1.17","volume":"171","author":"AM Byers","year":"2003","unstructured":"Byers AM, Kemball CC, Moser JM, Lukacher AE. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol. 2003;171:17\u201321.","journal-title":"J Immunol"},{"key":"1372_CR25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.addr.2011.07.003","volume":"64","author":"J Kunisawa","year":"2012","unstructured":"Kunisawa J, Kurashima Y, Kiyono H. Gut-associated lymphoid tissues for the.development of oral vaccines. Adv Drug Deliv Rev. 2012;64:523\u201330.","journal-title":"Adv Drug Deliv Rev"},{"key":"1372_CR26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbrc.2009.02.075","volume":"381","author":"F Yuanhui","year":"2009","unstructured":"Yuanhui F et al. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicitsprotective immunity in BALB\/c mice. Biochem Biophys Res Commun. 2009;381:528\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"1372_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00452-X","volume":"208","author":"KA Foster","year":"2000","unstructured":"Foster KA, Avery ML, Yazdanian M, Audus KL. Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm. 2000;208:1\u201311.","journal-title":"Int J Pharm"},{"key":"1372_CR28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1023\/A:1018869601502","volume":"16","author":"C Witschi","year":"1999","unstructured":"Witschi C, Mrsny RJ. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharm Res. 1999;16:382\u201390.","journal-title":"Pharm Res"},{"key":"1372_CR29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2010.06.017","volume":"148","author":"X Sun","year":"2010","unstructured":"Sun X et al. Enhanced in vivo gene expression mediated by listeriolysin O incorporated anionic LPDII: its utility in cytotoxic T lymphocyte-inducing DNA vaccine. J Control Release. 2010;148:219\u201325.","journal-title":"J Control Release"},{"key":"1372_CR30","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","volume":"170","author":"JC Fitzgerald","year":"2003","unstructured":"Fitzgerald JC et al. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J Immunol. 2003;170:1416\u201322.","journal-title":"J Immunol"},{"key":"1372_CR31","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1016\/S0264-410X(01)00259-6","volume":"32","author":"PD Becker","year":"2001","unstructured":"Becker PD et al. Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice. Vaccine. 2001;32:4603\u20139.","journal-title":"Vaccine"},{"key":"1372_CR32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","volume":"9","author":"VC Huber","year":"2006","unstructured":"Huber VC et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a to protective immunity against influenza antibodies. Clin Vaccine Immunol. 2006;9:981\u201390.","journal-title":"Clin Vaccine Immunol"},{"key":"1372_CR33","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.4049\/jimmunol.180.9.6159","volume":"180","author":"K Yang","year":"2008","unstructured":"Yang K et al. A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection. J Immunol. 2008;180:6159\u201367.","journal-title":"J Immunol"},{"key":"1372_CR34","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1016\/j.vaccine.2011.06.085","volume":"29","author":"MP Girard","year":"2011","unstructured":"Girard MP et al. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review. Vaccine. 2011;29:6191\u2013218.","journal-title":"Vaccine"},{"key":"1372_CR35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006;6:148\u201358.","journal-title":"Nat Rev Immunol"},{"key":"1372_CR36","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1128\/JVI.72.8.6646-6656.1998","volume":"72","author":"Z Smit-Mcbride","year":"1998","unstructured":"Smit-Mcbride Z et al. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4+ T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J Virol. 1998;72:6646\u201356.","journal-title":"J Virol"},{"key":"1372_CR37","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/IAI.65.7.2676-2684.1997","volume":"65","author":"C Bergquist","year":"1997","unstructured":"Bergquist C et al. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun. 1997;65:2676\u201384.","journal-title":"Infect Immun"},{"key":"1372_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10611860701637966","volume":"16","author":"B Sl\u00fctter","year":"2008","unstructured":"Sl\u00fctter B, Hagenaars N, Jiskoot W. Rational design of nasal vaccines. J Drug Target. 2008;16:1\u201317.","journal-title":"J Drug Target"},{"key":"1372_CR39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/10430349950018535","volume":"10","author":"S Sandra","year":"1999","unstructured":"Sandra S et al. Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum Gene Ther. 1999;10:775\u201386.","journal-title":"Hum Gene Ther"},{"key":"1372_CR40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","volume":"283","author":"JE Schmitz","year":"1999","unstructured":"Schmitz JE et al. Control of viremia in simianimmunodeficiency virus infection by CD8 lymphocytes. Science. 1999;283:857\u201360.","journal-title":"Science"},{"key":"1372_CR41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","volume":"189","author":"X Jin","year":"1999","unstructured":"Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, et al. Dramatic rise in plasma viremia after CD8 T celldepletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999;189:991\u20138.","journal-title":"J Exp Med"},{"key":"1372_CR42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ymthe.2005.10.006","volume":"13","author":"J Chen","year":"2006","unstructured":"Chen J, Wu Q, Yang P, Hsu HC, Mountz JD. Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy. Mol Ther. 2006;13:260\u20137.","journal-title":"Mol Ther"},{"key":"1372_CR43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-134-9_Part_1-200105010-00013","volume":"134","author":"C Hogan","year":"2001","unstructured":"Hogan C, Hammer S. Host determinants in HIV infection and disease. Ann Intern Med. 2001;134:761.","journal-title":"Ann Intern Med"},{"key":"1372_CR44","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1128\/JVI.73.8.6715-6720.1999","volume":"73","author":"SA Kalams","year":"1999","unstructured":"Kalams SA et al. Association between virus-specific cytotoxic T-lymphocyte and helper response in human immunodeficiency virus type 1 infection. J Virol. 1999;73:6715.","journal-title":"J Virol"},{"key":"1372_CR45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm990","volume":"10","author":"W Lu","year":"2004","unstructured":"Lu W, Arraes LC, Ferreira WT, Andrieu JM. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med. 2004;10:135\u201365.","journal-title":"Nat Med"},{"key":"1372_CR46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1046-2023(03)00135-X","volume":"31","author":"NA Doria-Rose","year":"2003","unstructured":"Doria-Rose NA, Haigwood NL. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods. 2003;31:207\u201316.","journal-title":"Methods"},{"key":"1372_CR47","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1586\/erv.12.81","volume":"11","author":"A Gebril","year":"2012","unstructured":"Gebril A et al. Optimizing efficacy of mucosal vaccines. Expert Rev Vaccines. 2012;11:1139\u201355.","journal-title":"Expert Rev Vaccines"},{"key":"1372_CR48","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","volume":"57","author":"MI Ugwoke","year":"2005","unstructured":"Ugwoke MI et al. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev. 2005;57:1640\u201365.","journal-title":"Adv Drug Deliv Rev"},{"key":"1372_CR49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-010-0696-0","volume":"89","author":"L Irina","year":"2011","unstructured":"Irina L et al. Development of adenoviral vector-based mucosal vaccine against influenza. J Mol Med. 2011;89:331\u201341.","journal-title":"J Mol Med"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1372-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-014-1372-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1372-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T19:28:11Z","timestamp":1597778891000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-014-1372-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,3]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1007\/s11095-014-1372-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,3]]}}}